• 1
    Wilmut, I.,Schnieke, A. E.,McWhir, J.,Kind, A. J., and Campbell, K. H. ( 1997) Viable offspring derived from fetal and adult mammalian cells. Nature 385, 810813.
  • 2
    French, A. J.,Adams, C. A.,Anderson, L. S.,Kitchen, J. R.,Hughes, M. R., and Wood, S. H. ( 2008) Development of human cloned blastocysts following somatic cell nuclear transfer with adult fibroblasts. Stem Cells 26, 485493
  • 3
    Thomson, J. A.,Itskovitz-Eldor, J.,Shapiro, S. S.,Waknitz, M. A.,Swiergiel, J. J.,Marshall, V. S., and Jones, J. M. ( 1998) Embryonic stem cell lines derived from human blastocysts. Science 282, 11451147.
  • 4
    Takahashi, K. and Yamanaka, S. ( 2006) Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126, 663676.
  • 5
    Kim, J. B.,Greber, B.,Araúzo-Bravo, M. J.,Meyer, J.,Park, I. H.,Zaehres, H., and Scholer, H. R. ( 2009) Direct reprogramming of human neural stem cells by OCT4. Nature 461, 643649.
  • 6
    Chin, M. H.,Mason, M. J.,Xie, W.,Volinia, S.,Singer, M.,Peterson, C.,Ambartsumyan, G.,Aimiuwu, O.,Richter, L.,Zhang, J.,Khvorostov, I.,Ott, V.,Grunstein, M.,Lavon, N.,Benvenisty, N.,Croce, C. M.,Clark, A. T.,Baxter, T.,Pyle, A. D.,Teitell, M. A.,Pelegrini, M.,Plath, K., and Lowry, W. E. ( 2009) Induced pluripotent stem cells and embryonic stem cells are distinguished by gene expression signatures. Cell Stem Cell 5, 111123
  • 7
    Meissner, A.,Wernig, M., and Jaenisch R. ( 2007) Direct reprogramming of genetically unmodified fibroblasts into pluripotent stem cells. Nat. Biotechnol. 25, 11771181.
  • 8
    Maherali, N.,Sridharan, R.,Xie, W.,Utikal, J.,Eminli, S.,Arnold, K.,Stadtfeld, M.,Yachechko, R.,Tchieu, J.,Jaenisch, R.,Plath, K., and Hochedlinger, K. ( 2007) Directly reprogrammed fibroblasts show global epigenetic remodeling and widespread tissue contribution. Cell Stem Cell 1, 5570.
  • 9
    Nakagawa, M.,Koyanagi, M.,Tanabe, K.,Takahashi, K.,Ichisaka, T.,Aoi, T.,Okita, K.,Mochiduki, Y.,Takizawa, N., and Yamanaka, S. ( 2008) Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts. Nat. Biotechnol. 26, 101106.
  • 10
    Okita, K.,Ichisaka, T., and Yamanaka, S. ( 2007) Generation of germline-competent induced pluripotent stem cells. Nature 448, 313317.
  • 11
    Wernig, M.,Meissner, A.,Foreman, R.,Brambrink, T.,Ku, M.,Hochedlinger, K.,Bernstein, E. B., and Jaenisch R. ( 2007) In vitro reprogramming of fibroblasts into apluripotent ES-cell-like state. Nature 448, 318324.
  • 12
    Takahashi, K.,Tanabe, K.,Ohnuki, M.,Narita, M.,Ichisaka, T.,Tomoda, K., and Yamanaka, S. ( 2007) Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131, 861872.
  • 13
    Toma, J. G.,Akhavan, M.,Fernandes, K. J.,Barnabé-Heider, F.,Sadikot, A.,Kaplan, D. R., and Miller, F. D. ( 2001) Isolation of multipotent adult stem cells from the dermis of mammalian skin. Nature Cell Biol. 3, 778784.
  • 14
    Liu, S. V. ( 2008) iPS Cells: a more critical review. Stem Cells Dev. 17, 391397
  • 15
    Masaki, H.,Ishikawa, T.,Takahashi, S.,Okumura, M.,Sakai, N.,Haga, M.,Kominami, K.,Migita, H.,McDonald, F.,Shimada, F., and Sakurada, K. ( 2008) Heterogeneity of Pluripotent marker gene expression in colonies generated in human iPS cell induction culture. Stem Cell Res. 2, 105115.
  • 16
    Yamanaka, S. ( 2009) Elite and stochastic models for induced pluripotent stem cell generation. Nature 460, 4952
  • 17
    Brambrink, T.,Foreman, R.,Welstead, G. G.,Lengner, C.,Wernig, M.,Suh, H., and Jaenisch R. ( 2008). Sequential expression of pluripotency markers during direct reprogramming of mouse somatic cells. Cell Stem Cell 2, 151159.
  • 18
    Lengner, C.,Camargo, F. D.,Hochedlinger, K.,Elstead, G.,Zaidi, S.,Gokhale, S.,Scholer, H.,Tomilin, A., and Jaenisch, R. ( 2007) Oct4 expression is not required for mouse somatic stem cell self-renewal. Cell Stem Cell 1, 403415.
  • 19
    Zangrossi, S.,Marabese, M.,Broggini, M.,Giordano, R.,D'Erasmo, M.,Montelatici, E.,Initini, D.,Neri, A.,Rebulla, P., and Lazzari, L. ( 2007) Oct-4 expression in adult human differentiated cells challenges its role as a pure stem cell marker. Stem Cells 25, 16751680.
  • 20
    Eminli, S.,Foudi, A.,Stadtfeld, M.,Maherali, N.,Ahfeldt, T.,Mostoslavsky, G.,Hock, H., and Hochedlinger, K. ( 2009) Differentiation stage determines potential of hematopoietic cells for reprogramming into induced pluripotent stem cells. Nat. Genet. 41, 96876.
  • 21
    Yu, J.,Hu, K.,Smuga-Otto, K.,Tian, S.,Stewart, R.,Slukvin, I., and Thomson, J. A. ( 2009) Human induced pluripotent stem cells free of vector and transgene sequences. Science 324, 797801
  • 22
    Zhou, H.,Wu, S.,Joo, J. Y.,Zhu, S.,Han, D. W.,Lin, T.,Trauger, S.,Bien, G.,Yao, S.,Zhu, Y.,Siuzdak, G.,Schöler, H. R.,Duan, L., and Ding, S. ( 2009) Generation of induced pluripotent stem cells using recombinant proteins. Cell. Stem Cell 4, 381384
  • 23
    Eckhardt, F.,Lewin, J.,Cortese, R.,Rakyan, V. K.,Attwood, J.,Burger, M.,Burton, J.,Cox, T. V.,Davies, R.,Down, T. A.,Haefliger, C.,Horton, R.,Howe, K.,Jackson, D. K.,Kunde, J.,Koenig, C.,Liddle, J.,Niblett, D.,Otto, T.,Pettett, R.,Seemann, S.,Thompson, C.,West, T.,Rogers, J.,Olek, A.,Berlin, K., and Beck, S. ( 2006) DNA methylation profiling of human chromosomes 6, 20 and 22. Nat. Genet. 12, 13781385
  • 24
    Kohda, T.,Inoue, K.,Ogonuki, N.,Miki, H.,Naruse, M.,Kaneko-Ishino, T.,Ogura, A., and Ishino, F. ( 2005) Variation in gene expression and aberrantly regulated chromosome regions in cloned mice. Biol. Reprod. 73, 13021311
  • 25
    Wang, Y.,Jiang, Y.,Liu, S.,Sun, X., and Gao S. ( 2009) Generation of induced pluripotent stem cells from humanβ-thalassemia ibroblast. Cells 19, 11201123
  • 26
    Miura, K.,Okada, Y.,Aoi, Y.,Okada, A.,Takahashi, K.,Okita, K.,Nakagawa, M.,Koyanagi, M.,Tanabe, K.,Ohnuki, M.,Ogawa, D.,Ikeda, E.,Okano, H., and Yamanaka, S. ( 2009) Variation in the safety of induced pluripotent stem cell lines. Nat. Biotechnol. 27, 743745
  • 27
    Trosko, J. E. ( 2006) From adult stem cells to cancer stem cells: Oct-4 Gene, cell-cell communication, and hormones during tumor promotion. Ann. N. Y. Acad. Sci. 1089, 3658.
  • 28
    Atlasi, Y.,Mowla, S. J.,Ziaee, S. A., and Bahrami, A. R. ( 2007) OCT-4, an embryonic stem cell marker, is highly expressed in bladder cancer. Int. J. Cancer 120, 15981602.
  • 29
    Li, X. L.,Eishi, Y.,Bai, Y. Q.,Sakai, H.,Akiyama, Y.,Tani, M.,Takizawa, T.,Koike, M., and Yuasa, Y. ( 2004) Expression of the SRY-related HMG box protein SOX2 in human gastric carcinoma. Int. J. Oncol. 24, 257263.
  • 30
    Tsukamoto, T.,Mizoshita, T.,Mihara, M.,Tanaka, H.,Takenaka, Y.,Yamamura, Y.,Nakamura, S.,Ushijima, T., and Takematsu, M. ( 2005) Sox2 expression in human stomach adenocarcinomas with gastric and gastric-and-intestinal-mixed phenotypes. Histopathology 46, 649658.
  • 31
    Sanada, Y.,Yoshida, K.,Ohara, M.,Oeda, M.,Konishi, K., and Tsutani Y. ( 2006) Histopathologic evaluation of stepwise progression of pancreatic carcinoma with immunohistochemical analysis of gastric epithelial transcription factor SOX2: comparison of expression patterns between invasive components and cancerous or nonneoplastic intraductal components. Pancreas 32, 164170.
  • 32
    Sanada, Y.,Yoshida, K.,Konishi, K.,Oeda, M.,Ohara, M., and Tsutani, Y. ( 2006) Expression of gastric mucin MUC5AC and gastric transcription factor SOX2 in ampulla of vater adenocarcinoma: comparison between expression patterns and histologic subtypes. Oncol. Rep. 15, 11571161.
  • 33
    Schmitz, M.,Temme, A.,Senner, V.,Ebner, R.,Schwind, S.,Stevanovic, S.,Wehner, R.,Schackert, G.,Schackert, H. K.,Fussel, M.,Bachmann, M.,Rieber, E. P., and Weigle, B. ( 2007) Identification of SOX2 as a novel glioma-associated antigen and potential target for T cell-based immunotherapy. Br. J. Cancer 96, 12931301.
  • 34
    Rodriguez-Pinilla, S. M.,Sarrio, D.,Moreno-Bueno, G.,Rodruguez-Gil, Y.,Martinez, M. A.,Hernandez, L.,Hardisson, D.,Reis-Filho, J. S., and Palacios, J. ( 2007) Sox2: a possible driver of the basal-like phenotype in sporadic breast cancer. Mod. Pathol. 20, 474481.
  • 35
    Phi, J. H.,Park, H.,Kim, S. K.,Paek, S. H.,Kim, J. H.,Lee, Y. J.,Cho, B.-K.,Park, C.-K.,Lee, D.-H., and Wang, K.-C. ( 2008) Sox2 expression in brain tumors: a reflection of the neuroglial differentiation pathway. Am. J. Surg. Pathol. 32, 103112.
  • 36
    Tanaka, Y.,Era, T.,Nishikawa, S., and Kawamata, S. ( 2007) Forced expression of Nanog in hematopoietic stem cells results in a gammadeltaT-cell disorder. Blood 110, 107115.
  • 37
    Foster, K. W.,Ren, S.,Louro, I. D.,Lobo-Ruppert, S. M.,McKieBell, P.,Grizzle, W.,Hayes, M. R.,Broker, T. R.,Chow, L. T., and Ruppert, J. M. ( 1999) Oncogene expression cloning by retroviral transduction of adenovirus E1A-immortalized rat kidney RK3E cells: transformation of a host with epithelial features by c-MYC and the zinc finger protein GKLF. Cell. Growth Differ. 10, 423434.
  • 38
    Foster, K. W.,Liu, Z.,Nail, C. D.,Lie, X.,Fitzgerald, T. J.,Bailey, S. K.,Frost, A. R.,Louro, I. D.,Townes, T. M.,Paterson, A. J.,Kudlow, J. E.,Lobo-Ruppert, S. M., and Ruppert J. M. ( 2005) Induction of KLF4 in basal keratinocytes blocks the proliferation-differentiation switch and initiates squamous epithelial dysplasia. Oncogene 24, 14911500.
  • 39
    Utikal, J.,Polo, M.,Stadtfeld, M.,Maherali, N.,Kulalert, W.,Walsh, R. W.,Khalil, A.,Rheinwald, J. G., and Hochedlinger, K. ( 2009) Immortalization eliminates a roadblock during cellular reprogramming into iPS cells. Nature 460, 11451148.
  • 40
    Krizhanovsky, V. and Lowe, S. T. ( 2009) The promises and perils of p53. Nature 460, 10851086.
  • 41
    Kim, J. B.,Sebastiano, V.,Wu, G., and Marcos, J. ( 2009) Oct4-Induced Pluripotency in Adult Neural Stem Cells. Cell 136, 411419,
  • 42
    Park, I. H.,Arora, N.,Huo, H.,Maherali, N., and Daley, G. Q. ( 2008) Disease-specific induced pluripotent stem (iPS) cells. Cell 134, 877886.
  • 43
    Dressel, R.,Guan, K.,Nolte, J.,Elsner, L.,Monecke, S.,Nayernia, K.,Hasenfuss, G., and Engel W. ( 2009) Multipotent adult germ-line stem cells, like other pluripotent stem cells, can be killed by cytotoxic T lymphocytes despite low expression of major histocompatibility complex class I molecules. Biol. Direct 4, 31